Vaccines to curb F&P Healthcare sales

Vaccines to curb F&P Healthcare sales
Dan Brunskill
Shares in Fisher & Paykel Healthcare surged last week as investors were swayed by sustained high sales numbers, but Forsyth Barr is warning demand may begin to fade as covid vaccinations roll out globally.The healthcare manufacturer saw its shares jump more than 5 percent on Friday on the news that revenue was up 73 percent in the nine months ended December, pulling the stock back above $35.Chief executive Lewis Gradon said high rates of covid-19 hospitalisations had driven strong demand for its hospital products, which are used as a front-...

More Markets

'So much volatility': NZ sharemarket up nearly 1%
Markets Market Close

'So much volatility': NZ sharemarket up nearly 1%

The S&P/NZX 50 Index closed at 11,891.44, up 115.56 points or 0.98%.

'Amateurs': NZME shareholder turns on coup plotters
Markets

'Amateurs': NZME shareholder turns on coup plotters

Shareholder now says Jim Grenon's plan to topple board would be dangerous.

Summerset's first quarter sales up 14%
Property

Summerset's first quarter sales up 14%

Summerset chief executive Scott Scoullar says the retirement village and aged care operator had a strong February and March. In a quarterly trading update to the NZX on Tuesday, Summerset Group reported 290 sales for the quarter ending March 31, with 132 new sales and 158 resales...